PULIKE issued a profit forecast, expecting a year-on-year increase of 44.70% to 64.98% in net profit attributable to the parent company in the first half of the year

PULIKE expects that the net profit attributable to the parent company in the first half of 2025 will increase by 44.70% to 64.98% year-on-year, reaching between 107 million and 122 million yuan. The launch of new products such as the live vaccine for pseudorabies in pigs and the adenovirus series five-in-one vaccine for poultry has driven performance growth, and sales of pet-related products continue to grow rapidly. The company optimizes costs and strengthens sales expense control through marketing system reform and lean production management to ensure the achievement of sales targets